发明名称 USE OF GLA OR DGLA FOR PREPARING A MEDICAMENT TO REDUCE PRODUCTION OF UNDESIRABLE METABOLITES FROM ARACHIDONIC ACID
摘要 A method of preparation of a medicament for reducing the risk of production of undesirable metabolites from free bodily AA on administration of AA to currect deficiency thereof, wherein GLA and/or DGLA as such or in the form of a salt dissociated at physiological pH is prepared as said medicament alone or incorporated in a pharmaceutically acceptable diluent or carrier.
申请公布号 NZ234528(A) 申请公布日期 1997.06.24
申请号 NZ19900234528 申请日期 1990.07.16
申请人 SCOTIA HOLDINGS PLC (FORMERLY EFAMOL HOLDINGS PLC) 发明人 HORROBIN, DAVID FREDERICK
分类号 A23L33/20;A61K31/20;A61K31/23;A61P3/04;A61P3/08 主分类号 A23L33/20
代理机构 代理人
主权项
地址